Risk Analysis of Prostate Cancer Development Following Five-alpha Reductase Inhibitor Treatment for Benign Prostate Hyperplasia
Anticancer Research · 2023
DOI: 10.21873/anticanres.16185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Li-Wen Chang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C. Hauptthemen laut MEDLINE: 5-alpha Reductase Inhibitors, Prostatic Hyperplasia, Prostatic Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
- Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, R.O.C.
- Department of Applied Chemistry, National Chi Nan University, Nantou, Taiwan, R.O.C.
- Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
- Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.; fisherfishli@yahoo.com.tw.
- Division of Surgical Intensive Care Unit, Department of Intensive Care, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
Zitieren
APA
Chang, L. W., Wang, S. S., Yang, C. K., Lu, K., Chen, C. S., Cheng, C. L., Hung, S. C., Chiu, K. Y., Hsu, C. Y., & Li, J. R. (2023). Risk Analysis of Prostate Cancer Development Following Five-alpha Reductase Inhibitor Treatment for Benign Prostate Hyperplasia. Anticancer Research. https://doi.org/10.21873/anticanres.16185
Vancouver
Chang LW, Wang SS, Yang CK, Lu K, Chen CS, Cheng CL, et al. Risk Analysis of Prostate Cancer Development Following Five-alpha Reductase Inhibitor Treatment for Benign Prostate Hyperplasia. Anticancer Research. 2023. doi:10.21873/anticanres.16185
BibTeX
@article{Chang2023,
author = {Chang, Li-Wen and Wang, Shian-Shiang and Yang, Cheng-Kuang and Lu, Kevin and Chen, Chuan-Shu and Cheng, Chen-Li and Hung, Sheng-Chun and Chiu, Kun-Yuan and Hsu, Chiann Yi and Li, Jian-Ri},
title = {Risk Analysis of Prostate Cancer Development Following Five-alpha Reductase Inhibitor Treatment for Benign Prostate Hyperplasia},
journal = {Anticancer Research},
year = {2023},
doi = {10.21873/anticanres.16185}
}
EUVIMED